Gaurav Shah's Net Worth
$26 Million
Who is Gaurav Shah?
Gaurav Shah has an estimated net worth of $26 Million. This is based on reported shares across multiple companies, which include Talaris Therapeutics, Inc., and ROCKET PHARMACEUTICALS, INC..
SEC CIK
Gaurav Shah's CIK is 0001725922
Past Insider Trading and Trends
2023 was Gaurav Shah's most active year for acquiring shares with 9 total transactions. Gaurav Shah's most active month to acquire stocks was the month of January. 2021 was Gaurav Shah's most active year for disposing of shares, totalling 12 transactions. Gaurav Shah's most active month to dispose stocks was the month of February. 2022 saw Gaurav Shah paying a total of $381,513.00 for 428,813 shares, this is the most they've acquired in one year. In 2021 Gaurav Shah cashed out on 278,880 shares for a total of $8,984,927.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Talaris Therapeutics, Inc. (TRML) Snapshot price: $35.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ROCKET PHARMACEUTICALS, INC. (RCKT) Snapshot price: $28.91
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.85% | 99.6K |
$23.35 | -$228,596.50 | 728.07K |
Feb 14 - May 16
| |||
Form 4
| +8.05% | 46.3K |
$29.84 | -$604,875.94 | 621.34K |
Feb 16
| |||
Form 4
| -7.53% | -46.83K |
—
|
—
| 575.03K |
Feb 14
| |||
Form 4
| -1.48% | -7.98K |
—
|
—
| 532.83K |
Nov 14
| |||
Form 4
| -0.90% | -4.77K |
$15.47 | -$73,750.26 | 524.85K |
Aug 17
| |||
Form 4
| +1.53% | 7.98K |
—
|
—
| 529.62K |
Aug 14
| |||
Form 4
| -0.78% | -4.12K |
$21.38 | -$88,107.75 | 521.64K |
May 17
| |||
Form 4
| +1.54% | 7.98K |
—
|
—
| 525.76K |
May 14
| |||
Form 4
| -2.22% | -12.19K |
$19.06 | -$232,417.64 | 536.88K |
Feb 17
| |||
Form 4/A
| +6.07% | 31.44K |
—
|
—
| 549.08K |
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +4.44% | 22K |
$17.34 | $381,513.00 | 517.64K |
Feb 7
| |||
Form 4
| -5.66% | -29.76K |
$46.26 | -$1,376,789.35 | 495.64K |
Scheduled
|
Mar 31 - Apr 1
| ||
Form 4
| -7.87% | -97.36K |
$22.35 | -$7,479,901.41 | 1.14M |
Scheduled
|
Mar 30 - Mar 31
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +6.00% | 58.28K |
$7.11 | -$410,750.35 | 1.03M |
Mar 24
| |||
Form 4
| +41.31% | 283.77K |
$10.29 | $33.05 | 970.72K |
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
| -9.83% | -74.90K |
$17.17 | -$1,286,272.00 | 686.95K |
Scheduled
|
Mar 1 - Mar 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||